JP2024532853A5 - - Google Patents
Info
- Publication number
- JP2024532853A5 JP2024532853A5 JP2024510296A JP2024510296A JP2024532853A5 JP 2024532853 A5 JP2024532853 A5 JP 2024532853A5 JP 2024510296 A JP2024510296 A JP 2024510296A JP 2024510296 A JP2024510296 A JP 2024510296A JP 2024532853 A5 JP2024532853 A5 JP 2024532853A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- hpv
- sequence encoding
- papillomavirus
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21191940.2 | 2021-08-18 | ||
| EP21191940.2A EP4137153A1 (en) | 2021-08-18 | 2021-08-18 | Therapeutic papilloma virus vaccines |
| PCT/EP2022/073016 WO2023021116A1 (en) | 2021-08-18 | 2022-08-17 | Therapeutic papilloma virus vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532853A JP2024532853A (ja) | 2024-09-10 |
| JP2024532853A5 true JP2024532853A5 (https=) | 2025-09-12 |
Family
ID=77398487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024510296A Pending JP2024532853A (ja) | 2021-08-18 | 2022-08-17 | 治療用パピローマウイルスワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250066427A1 (https=) |
| EP (2) | EP4137153A1 (https=) |
| JP (1) | JP2024532853A (https=) |
| KR (1) | KR20240095168A (https=) |
| CN (1) | CN117940156A (https=) |
| AU (1) | AU2022331111A1 (https=) |
| CA (1) | CA3229203A1 (https=) |
| MX (1) | MX2024002010A (https=) |
| WO (1) | WO2023021116A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4720309A1 (en) * | 2023-05-26 | 2026-04-08 | ProBioGen AG | Diploid recombinant nucleocytoplasmic large dna viral vectors |
| CN120607593A (zh) * | 2024-03-06 | 2025-09-09 | 诺未生物技术(无锡)有限公司 | 治疗hpv感染相关疾病的药物 |
| CN119569831B (zh) * | 2024-12-13 | 2026-04-28 | 深圳锦时生物科技有限公司 | 一种活性多肽及在预防和/或治疗hpv中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2457890A1 (en) * | 2001-08-23 | 2003-03-06 | Merck & Co., Inc. | Vaccine using papillomavirus e proteins delivered by viral vector |
| EP1957528B1 (en) | 2005-11-30 | 2012-11-07 | University of Copenhagen | A nucleotide vaccine |
| EP3552622A3 (en) | 2008-11-21 | 2019-12-04 | Københavns Universitet (University Of Copenhagen) | Priming of an immune response |
| GB201321384D0 (en) | 2013-12-04 | 2014-01-15 | Isis Innovation | Molecular adjuvant |
| GB201704417D0 (en) | 2017-03-20 | 2017-05-03 | Univ Copenhagen | Improved li vaccine adjuvant |
| US12576143B2 (en) | 2018-10-19 | 2026-03-17 | Nouscom Ag | Teleost invariant chain cancer vaccine |
-
2021
- 2021-08-18 EP EP21191940.2A patent/EP4137153A1/en not_active Withdrawn
-
2022
- 2022-08-17 JP JP2024510296A patent/JP2024532853A/ja active Pending
- 2022-08-17 CA CA3229203A patent/CA3229203A1/en active Pending
- 2022-08-17 AU AU2022331111A patent/AU2022331111A1/en active Pending
- 2022-08-17 MX MX2024002010A patent/MX2024002010A/es unknown
- 2022-08-17 EP EP22768288.7A patent/EP4387662A1/en active Pending
- 2022-08-17 KR KR1020247008839A patent/KR20240095168A/ko active Pending
- 2022-08-17 US US18/684,381 patent/US20250066427A1/en active Pending
- 2022-08-17 WO PCT/EP2022/073016 patent/WO2023021116A1/en not_active Ceased
- 2022-08-17 CN CN202280053653.9A patent/CN117940156A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021232660B2 (en) | HPV vaccines | |
| US7482015B2 (en) | Optimized expression of HPV 45 L1 in yeast | |
| JP2024532853A5 (https=) | ||
| JP4912885B2 (ja) | 酵母におけるｈｐｖ５８ｌ１の最適化発現 | |
| KR0164215B1 (ko) | 사람 유두종바이러스 제16형 e7 단백질상의 면역원성 서열을 갖는 폴리펩타이드 | |
| Motevalli et al. | Supercharged green fluorescent protein delivers HPV16E7 DNA and protein into mammalian cells in vitro and in vivo | |
| WO2024140162A1 (zh) | 人乳头瘤病毒hpv59 l1蛋白的表达和类病毒样颗粒及其制备方法 | |
| US6991795B1 (en) | Protein delivery system using human papillomavirus virus-like particles | |
| CN114539363B (zh) | 一种c端改造的人乳头瘤病毒11型l1蛋白及其用途 | |
| AU753391B2 (en) | Protein delivery system using human papillomavirus virus-like particles | |
| CN101952320A (zh) | 具有免疫原性的物质 | |
| KR102567627B1 (ko) | 인간 유두종 바이러스 타입 16의 l1 단백질의 변이체 | |
| CN105801704A (zh) | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 | |
| CA2323526A1 (en) | Formulation having a papilloma virus-specific protein, and the production and use thereof | |
| HK40082300A (en) | Hpv vaccines | |
| Bian et al. | Construction of a recombinant adenovirus vector of human papillomavirus type 16 L1_E7C |